Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer-MedSci.cn

Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer

Bullock, A; Grossman, J; Fakih, M; Lenz, H; Gordon, M; Margolin, K; Wilky, B; Mahadevan, D; Trent, J; Bockorny, B; Moser, J; Balmanoukian, A; Schlechter, B; Feliu, WO; Rosenthal, K; Bullock, B; Stebbing, J; Godwin, J; O'Day, S; Tsimberidou, A; El-Khoueiry, A

ANNALS OF ONCOLOGY, 2022; 33 (): S376

科室
- - 订阅+
  - 更多科室
工具
服务